Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2025 16:06 ET | Source: Memgen

Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer

Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer
August 06, 2025 04:09 ET | Source: Research and Markets

Docetaxel Market Growth Trends, Competitive Strategies and Forecasts, 2025-2033 | Generics Dominate Docetaxel Market with Cost-Effective Solutions Post Patent Expiry

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Docetaxel Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To...
July 25, 2025 10:40 ET | Source: Research and Markets

Metastatic Hormone Refractory Prostate Cancer Pipeline Market Research Report 2025 | In-depth Analysis of 180+ Companies and Over 200 Drugs in Development

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Metastatic Hormone...
May 08, 2025 04:17 ET | Source: Research and Markets

Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's...
September 25, 2024 04:09 ET | Source: Research and Markets

HER2 Positive Breast Cancer Treatment Pipeline Landscape 2024: Insight Report Reveals Over 60 Companies Developing Innovative Therapies

Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "HER2 Positive Breast Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The report encompasses an in-depth...
June 20, 2024 06:59 ET | Source: Research and Markets

Global KRAS Inhibitors Market & Clinical Trials Future Market Outlook 2030: 2 Approved KRAS Inhibitors and 90+ Drugs KRAS Inhibitors in Clinical Trials

Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Future Outlook 2030" report has been added to ResearchAndMarkets.com's offering. With the...
April 18, 2024 09:11 ET | Source: Research and Markets

World Metastatic Prostate Cancer Drug Landscape Research Report 2024: Comprehensive Insights about 90+ Companies and 110+ Pipeline Drugs

Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Prostate Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
February 29, 2024 04:06 ET | Source: Research and Markets

Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond

Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...
February 19, 2024 07:48 ET | Source: Research and Markets

China Oncology Drugs Market Report, 2023 and 2024-2028 - Cancer Prevention Takes Center Stage in China's National Health Agenda

Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "China Oncology Drugs Market, Size, Forecast 2024-2028, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
January 22, 2024 16:58 ET | Source: Research and Markets

Prostate Cancer Drugs Global Market Report 2024: Emerging Combination Therapies and Geographic Expansion to Propel the Global Prostate Cancer Drugs Market Through 2028

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This recent comprehensive study sheds...